Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.

Ryan C DillonJose-Alberto PalmaChristy L SpalinkDiana AltshulerLucy Norcliffe-KaufmannDavid FridmanJohn PapadopoulosJose Alberto Palma

Published in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society (2016)

Intravenous dexmedetomidine is safe in patients with FD and appears to be effective to treat refractory adrenergic crisis. Dexmedetomidine may be considered in FD patients who do not respond to conventional clonidine and benzodiazepine pharmacotherapy.

Keyphrases

cardiac surgery
public health
high dose
early onset
smoking cessation